Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma.
Shirane Y, Fujii Y, Ono A, Nakahara H, Hayes CN, Miura R, Murakami S, Sakamoto N, Uchikawa S, Fujino H, Nakahara T, Murakami E, Yamauchi M, Miki D, Kawaoka T, Arihiro K, Tsuge M, Oka S.
Shirane Y, et al. Among authors: hayes cn.
Cancers (Basel). 2024 Mar 28;16(7):1328. doi: 10.3390/cancers16071328.
Cancers (Basel). 2024.
PMID: 38611007
Free PMC article.